Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
93 studies found for:    INFLAMMATORY BOWEL DISEASE 3
Show Display Options
Rank Status Study
1 Recruiting 3D Laparoscopy Versus 2D Laparoscopy
Conditions: Colorectal Cancer;   Inflammatory Bowel Disease
Intervention:
2 Recruiting Introduction of Microsystems in a Level 3 Neonatal Intensive Care Unit
Conditions: Stress, Psychological;   Inflammatory Bowel Diseases;   Lung Diseases;   Infant Nutrition Disorders;   Eye Manifestations;   Neurodevelopmental Disorders
Intervention:
3 Completed A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease.
Conditions: Crohn's Disease;   Inflammatory Bowel Disease
Intervention: Drug: Probiotic - VSL#3
4 Completed Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D
Conditions: Crohn's Disease (CD);   Ulcerative Colitis (UC)
Intervention: Dietary Supplement: Vitamin D3
5 Recruiting The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease
Conditions: Crohn Disease;   Ulcerative Colitis
Intervention: Dietary Supplement: VSL#3 (Original De Simone formulation)
6 Recruiting Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Conditions: Anemia, Iron-Deficiency;   Inflammatory Bowel Disease;   Crohn's Disease
Interventions: Drug: Ferric Maltol;   Drug: Ferric Carboxy Maltose
7 Completed Weekly Vitamin D in Pediatric IBD
Conditions: Inflammatory Bowel Diseases;   Skin Pigmentation
Intervention: Dietary Supplement: Vitamin D3 (cholecalciferol)
8 Completed Vitamin D3 Supplementation in Pediatric IBD: Weely vs Daily Dosing Regimens
Condition: Inflammatory Bowel Disease (IBD)
Intervention: Dietary Supplement: Vitamin D-3
9 Recruiting A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Conditions: Colitis, Ulcerative;   Inflammatory Bowel Diseases
Interventions: Drug: Placebo IV;   Drug: Placebo SC;   Drug: Ustekinumab IV;   Drug: Ustekinumab SC
10 Recruiting The Effect of Vitamin D3 to Maintain Surgical Remission in Postoperative Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Vitamin D;   Drug: Placebo
11 Active, not recruiting A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)
Conditions: Crohn's Disease;   Colitis;   IBD;   Inflammatory Bowel Disease
Interventions: Drug: Placebo SC;   Drug: Placebo IV;   Drug: Ustekinumab 90 mg SC;   Drug: Ustekinumab 130 mg IV
12 Completed A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)
Conditions: Crohn's Disease;   Inflammatory Bowel Disease;   IBD;   Colitis
Interventions: Drug: Group 3: ustekinumab approximately 6 mg/kg;   Drug: Group 1: Placebo;   Drug: Group 2 ustekinumab 130 mg
13 Completed A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
Conditions: Crohn's Disease;   IBD;   Colitis;   Inflammatory Bowel Disease
Interventions: Drug: Group 2 ustekinumab 130 mg;   Drug: Group 3: ustekinumab approximately 6 mg/kg;   Drug: Group 1: Placebo
14 Unknown  Oral OKT3 for the Treatment of Active Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Oral OKT3
15 Unknown  Gastrointestinal Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit
Condition: Ulcerative Colitis
Intervention: Device: Motilis-3D-transit
16 Unknown  Gastrointestinal Transit Times and Motility in Severe Ulcerative Colitis Obtained by Motilis-3D-transit
Condition: Ulcerative Colitis
Intervention: Device: Motilis-3D transit
17 Unknown  A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: VSL#3
18 Recruiting Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)
Conditions: IBS;   Ulcerative Colitis, Active;   Ulcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms);   Healthy Controls;   Crohn's Disease, Active;   Crohn's Disease, Remission (6a: With IBS Symptoms, 6b: Without IBS Symptoms)
Intervention: Other: Sample collection
19 Completed Effect of VSL#3 on Intestinal Permeability in Pediatric Crohn's Disease
Condition: Crohn's Disease
Interventions: Dietary Supplement: VSL#3;   Dietary Supplement: Placebo
20 Unknown  The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's Disease
Condition: Crohn's Disease
Intervention: Dietary Supplement: VSL#3

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years